drugset / Trial / NCT05718518
Study to Evaluate Safety, Tolerability, PK and the Food Effect on PK of ASC11/RTV Tablets in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled phase I clinical study evaluating the safety, tolerability, and pharmacokinetics of ASC11 plus ritonavir tablets in healthy subjects and an open-label, cross-over study evaluating the effect of food on the pharmacokinetics of ASC11 plus ritonavir tablets
Timeline
- Start
- 2023-01-13
- Primary completion
- 2023-04-14
- Completion
- 2023-04-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASC11 | Unknown | 100 mg | — |
| Subject | ASC11 | Unknown | 200 mg | — |
| Subject | ASC11 | Unknown | 300 mg | — |
| Subject | ASC11 | Unknown | 400 mg | — |
| Subject | ASC11 | Unknown | 800 mg | — |
| Subject | RTV | Unknown | 100 mg | — |